Posters will be on display in Hall D. Please note that
even-numbered posters will be attended on Tuesday 5
April at 11.45-13.00 and odd-numbered posters will be
attended on Wednesday 6 April at 11.45-13.00.
Posters will be on display in the Main Foyer and Hewison Hall. Please note
that even-numbered posters will be attended on Tuesday 23 March at 12.00-13.00
and odd-numbered posters will be attended on Wednesday 24 March at 12.00-13.00.
| Bone |
| P1 |
Failure to normalise PTH during
the treatment of osteomalacia |
|
Peacey SR, Wright D & Harries MJ |
| |
|
| P2 |
Does leptin regulate bone
turnover in adult growth hormone deficiency? |
|
Joseph F, Ahmad AM, Wallace AM, White HD, Durham BH, Fraser WD &
Vora JP |
| |
|
| P3 |
Oral bisphosphonates may reverse
the decline in bone mineral density in adults with cystic fibrosis |
|
Cawood TJ, Smith D, Wen YC, Gibney J, Dodd JD, Au-Yeoung ML, McKenna M,
Fitzgerald O, Gallagher C & O'Shea D |
| |
|
| P4 |
The role of the growth
hormone-insulin-like growth factor-I (GH-IGF-I) axis in the aetiology of male idiopathic
osteoporosis |
|
Patel MBR, Arden NK, Masterson L, Phillips DIW, Swaminathan
R, Syddall HE, Wood PJ, Cooper C & Holt RIG |
| |
|
| P5 |
Growth hormone replacement is
important for the restoration of PTH circadian rhythmicity in older adult growth hormone
deficient patients |
|
White HD, Ahmad AM, Joseph F, Prabhakar VKB, Patwala A, Whittingham P,
Durham BH, Fraser WD & Vora JP |
| |
|
| P6 |
Parathyroid hormone and
phosphate circadian rhythms are altered in osteopaenic adult growth hormone deficient
patients |
|
White HD, Ahmad AM, Joseph F, Chandran S,Corlett P, Durham BH, Fraser
WD & Vora JP |
| |
|
| P7 |
Transdermal testosterone
replacement in men with evidence of borderline gonadal failure |
|
Merza Z, Mah PM, Blumsohn A, Meads D, McKenna S, Wylie K, Eastell R
& Ross RJM |
| |
|
| P8 |
Application of new
indices of bone activity for evaluation of the response to treatment of hyperthyroidism
and Paget's disease |
|
Smith D, Murray B, Gibney J, O'Shea D & McKenna TJ |
| |
|
| P9 |
Outcome of
parathyroidectomy for primary hyperparathyroidism in 249 consecutive patients |
|
Ma YT, Toogood AA, Campbell D, Ready AR & Gittoes NJL |
| |
|
| P10 |
Inactivating
progesterone metabolism in human osteoblasts |
|
Kaur K, Cooper MS, Arlt W, Stewart PM, Hewison M &
Quinkler M |
| |
|
| P11 |
Utility of
biochemical screening in the context of evaluating patients with a presumptive diagnosis
of osteoporosis |
|
Rajeswaran C, Spencer J & Orme SM |
|
|
| P12 |
Investigation of
seasonal reference intervals for 25-cholecalciferol (vitamin D) |
|
Donaldson A, Leung YH, Jackson DA, Hill PA & Chapman RS |
|
|
| P13 |
The role of local
corticosteroid generation in inflammation-associated bone loss |
|
Cooper MS, Filer A, Moore J, Emery P, Buckley CD, Hewison M
& Stewart PM |
|
|
| P14 |
Adenosine stimulates
IL-6 but inhibits osteoprotegerin secretion by osteoprogenitor cells |
|
Evans BAJ, Elford C & Ham J |
|
|
| P15 |
Growth retardation
following prenatal GC exposure is more pronounced in the female offspring and is
associated with raised serum IGF-I |
|
Mushtaq T, Farquharson C, Nyirenda M, Seawright E, Seckl J
& Ahmed SF |
|
|
| Comparative
endocrinology |
| P16 |
Developmental
changes in gonadal and adrenal steroidogenesis in the blue fox (Alopex lagopus) |
|
Osadchuk LV, Braastad BO, Hovland AL & Bakken M |
|
|
| P17 |
An appraisal of
biochemical assessment of hypogonadism and bio-available testosterone in adult men |
|
Malkin CJ, Morris PD, Channer KS & Jones TH |
|
|
| P18 |
Usefulness of
ultrasonography in girls with true precocious puberty before and after two years of
treatment with an LH-RH analogue |
|
Zosi P, Triantafyllidis G, Nikolaidou A, Karakaidos D,
Varhalama F, Kokori E & Karis C |
|
|
| P19 |
Changes in bone
mineral density in response to growth hormone replacement in adults with isolated growth
hormone deficiency compared with multiple pituitary hormone deficiencies |
|
Waterhouse M, Laureiro R, Walker D, Besser GM & Monson
JP |
|
|
| Cytokines
and growth factors |
| P20 |
Glucocorticoids
suppress macrophage migration inhibitory factor (MIF) expression in a cell-type specific
manner |
|
Alourfi Z, Donn R, Stevens A & Ray DW |
|
|
| P21 |
Responsiveness to
growth hormone throughout the menstrual cycle |
|
Gleeson HK & Shalet SM |
|
|
| P22 |
The effect of
testosterone replacement on endogenous inflammatory cytokines and lipid profiles in
hypogonadal men |
|
Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS &
Jones TH |
|
|
| P23 |
Effects of estrogen
on leptin signalling and leptin-induced TNF-alpha production |
|
Fazeli M, Zarkesh-Esfahani SH, Maamra M & Ross RJM |
|
|
| P24 |
Excessive daytime
sleepiness associated with hypercytokinaemia in POEMS |
|
Wong SPY, Cresswell P, English P, Wilding JPH, Huda M,
Pazmany L, Pinkney JH & Hart IK |
|
|
| P25 |
Effects of long term
growth hormone replacement on leptin and body composition in adult growth hormone
deficiency |
|
Joseph F, Ahmad AM, Wallace AM, White HD, Durham BH, Fraser
WD & Vora JP |
|
|
| P26 |
GHR-GPI insertion
into target CHO cell membranes |
|
Gavalas NG, Zarkesh-Esfahani H, Wilkinson IR, Pradhananga
SL, Beghadi C, Baumann GP, Wu Z, Artymiuk PJ, Sayers JR & Ross RJM |
|
|
| P27 |
Angiogenesis and
lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour
behaviour |
|
Garcia de la Torre N, Buley I, Wass JAH, Jackson DG &
Turner HE |
|
|
| P28 |
Adrenomedullin mRNA
and peptide content are increased in skin following wounding |
|
Renshaw D, Kapas S & Hinson JP |
|
|
| P29 |
Basic fibroblast
growth factor (FGF2) in hypothalamus, neurohypophysis and choroid plexus: dehydration
supports a putative linkage with arginine vasopressin and fluid balance |
|
Gonzalez AM, Taylor WM, Stopa EG, King JC, Duncan JA, Baird
A & Johanson CE |
|
|
| P30 |
Comparison of IL-1
alpha induced gene expression in normal human ovarian surface epithelial cells and ovarian
cancer cells |
|
Gubbay O, Guo W, Rae MT, Niven D & Hillier SG |
|
|
| P31 |
Thyroid hormone
regulates heparan sulphate proteoglycans in the growth plate |
|
Bassett JHD, Swinhoe R & Williams GR |
|
|
| P32 |
Urinary human
chorionic gonadotrophin (hCG) associated proteins: isolation and characterisation by
peptide identification mass spectrometry |
|
Iles RK, Malatos S, Butler SA, Neubert H & Kicman AT |
|
|
| Diabetes,
metabolism and cardiovascular |
| P33 |
Non-alcoholic fatty
liver disease among Saudi type-2 diabetics attending medical outpatient clinic |
|
Akbar DH & Kawther AH |
|
|
| P34 |
The effect of DHT on
the regulation of therenin-angiotensin system in human abdominal subcutaneous adipocytes:
implications for PCOS |
|
Harte AL, Fowler AE, Rodriguez-Cuenca S, Chetty R, Fisher
FM, Anderson LA, Roca P, Kumar S, Matyka K & McTernan PG |
|
|
| P35 |
The effect of body
mass index on duration of intensive care stay and in-hospital mortality after cardiac
surgery in an Irish centre |
|
Cawood TJ, O'Shea D, Dowd N, McGovern E, Tolan M, Young V,
O'Connell M & Lyons FM |
|
|
| P36 |
A7r5 rat aortic
vascular smooth muscle cell apoptosis is reduced by testosterone |
|
Kerry KE, Clark S, Jones RD, Channer KS & Jones TH |
|
|
| P37 |
Mitogen-induced
apoptosis in A7r5 rat aortic vascular smooth muscle cells is not effected by testosterone |
|
Kerry KE, Clark S, Jones RD, Channer KS & Jones TH |
|
|
| P38 |
Reduced insulin
content and secretory capacity in the adult offspring of rats exposed to a high fat diet
in pregnancy |
|
Persaud SJ, Taylor PD, Poston L, Asare-Anane H, Burns CJ
& Jones PM |
|
|
| P39 |
A randomised
controlled trial of laser treatment among hirsute women with polycystic ovary syndrome |
|
Clayton W, Lipton M, Sherr L, Rustin M & Elford J |
|
|
| P40 |
Understanding the
fetal origins of the metabolic syndrome and its amplification by obesity; high fat feeding
potentiates the programming of hepatic insulin resistance by antenatal dexamethasone in
rats |
|
Drake AJ, Raubenheimer PJ, Seckl JR & Walker BR |
|
|
| P41 |
The N363S
polymorphism of the glucocorticoid receptor in South Asians in the north east |
|
Syed AA, Irving JAE, Redfern CPF, Hall AG, Unwin NC, White
M, Bhopal RS, Alberti KGMM & Weaver JU |
|
|
| P42 |
PYY deficiency may
reinforce obesity |
|
Le Roux CW, Aylwin SJB, Batterham RL, Borg CM, Wynne K,
Hunt C, Coyle F, Ghatei MA, Patel A & Bloom SR |
|
|
| P43 |
Improvements in
glucose utilisation immediately following exercise in patients with and without type 2
diabetes seem to be independent of improvements in insulin sensitivity |
|
MacDonald AL, Harrison M, Bone AJ & Watt PW |
|
|
| P44 |
Effect of size at
birth on glucose tolerance in pigs at 5 months of age |
|
Perkins KS, Laws J, Litten JC, Corson AM & Clarke L |
|
|
| P45 |
Transcriptional
interference by novel human PPARgamma mutants associated with lipodystrophic insulin
resistance |
|
Agostini M, Schoenmakers E, Smith AG, Szatmari I,
Rajanayagam O, Savage DB, Mitchell C, Clarke M, Zalin AM, Trembath RC, Kumar S, Schwabe
JWR, Nagy L, O'Rahilly S, Gurnell M & Chatterjee VKK |
|
|
| P46 |
Single nucleotide
polymorphisms within oxidative stress genes affect arterial compliance: gene function
relationships |
|
Drummond RS, Brosnan MJ, Tan C, Kirk A, Hamilton CA,
Connell JMC & Dominiczak AF |
|
|
| P47 |
A novel
non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of
metabolic syndrome in murine disease models |
|
Thieringer R, Balkovec JM, Chen HY, Frazier E, Le Grand CB,
Li Z, Metzger JM, Mundt SS, Nunes CN, Strowski M, Olson SH, Robertson N, Strack AM,
Schaeffer JM, Wright SD, Zhang BB & Hermanowski-Votska A |
|
|
| P48 |
Mechano-receptors
and cell-to-cell communication in the human collecting duct: functional involvement of
TRPV4 and connexin-43 |
|
Hills CE, Wheelans DC, Ronco PM, Bland R & Squires PE |
|
|
| P49 |
Increased C-jun N
terminal kinase (JNK) activity may link insulin resistance and inflammation in human
central obesity |
|
Fowler AE, da Silva NF, Burman C, Harte AL, McTernan PG
& Kumar S |
|
|
| P50 |
Circulating
pro-inflammatory cytokines and epicardial expression of resistin and TNF-alpha are
increased in patients with cardiovascular disease |
|
Baker AR, Quinn DW, da Silva NF, McTernan CL, Harte AL,
Bonser RS, Kumar S & McTernan PG |
|
|
| P51 |
Relation of plasma
homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2
diabetic patients |
|
Akalin A, Alatas O, Colak O, Sahin F & Efe B |
|
|
| P52 |
The IGF system
influences prevalence of the metabolic syndrome in a population with high rates of
cardiovascular disease |
|
Heald AH, Anderson SG, Vyas A, Patel J, Siddals KW,
Cruickshank JK & Gibson JM |
|
|
| P53 |
Investigation and
management of severe hyponatraemia - cause for concern? |
|
Huda MSB, Gill GV, Wile D, Skagen K, Boyd A, Watson ID
& van Heynigen C |
|
|
| P54 |
TLR mediated
activation of the innate immune response in human adipocytes with associated
down-regulation of adiponectin secretion and elevated TNF-alpha and IL-6 levels |
|
Fisher FFM, Creely S, Burman C, Harte AL, Chetty R,
Valsamakis G, McTernan PG & Kumar S |
|
|
| P55 |
Expression of
mineralocorticoid effector mechanisms in renal biopsies of patients with severe
proteinuria |
|
Quinkler M, Zehnder D, Lepenies J, Hughes S, Lipkin GW,
Hewison M & Stewart PM |
|
|
| P56 |
Testosterone
regulates renal expression of the alpha-subunit of the epithelial sodium channel
(alpha-ENaC) |
|
Quinkler M, Bujalska IJ, Kaur K, Hughes S, Hewison M &
Stewart PM |
|
|
| P57 |
Protective effects
of phytoestrogens against oxidative stress in human endothelial cells |
|
Zhong W, Adams IP, Adams RL & Atkin SL |
|
|
| P58 |
Targeted RNA
interference to selectively modulate expression of PPARgamma2 and -1 isoforms |
|
Schoenmakers E, Hadaschick DH, O'Rahilly S &
Chatterjee VKK |
|
|
| P59 |
Quantitative
analysis of glucose and insulin sensing genes in the hypothalami of Zucker diabetic fatty
(ZDF) rats |
|
Gyte AC, Pritchard LE, Brennand JC & White A |
|
|
| P60 |
Increased aromatase
expression in human subcutaneous adipose tissue in obesity |
|
Wake DJ, Elferink C, Rask E, Westerbacka J, Livingstone
DEW, Soderberg S, Yki-Jarvinen H, Olsson T, Andrew R & Walker BR |
|
|
| P61 |
PPARgamma2 and
RXRalpha are required for the transcriptional activation of the melanocortin 2 receptor
during adipocyte differentiation |
|
Noon LA, Clark AJL & King PJ |
|
|
| P62 |
Physiological
concentrations of testosterone inhibit extracellular calcium entry via voltage-gated
calcium channels in A7r5 vascular smooth muscle cells |
|
Hall J, Jones RD, Kang P, Channer KS, Peers C & Jones
TH |
|
|
| P63 |
Testosterone
inhibits Ca2+ currents in A7r5 vascular smooth muscle cells, and in HEK293
cells stably expressing the alpha1C subunit of L-type Ca2+ channels (CaV1.2)
and alpha1H T-type Ca2+ channels (CaV3.2) |
|
Scragg JL, Jones RD, Channer KC, Jones TH & Peers C |
|
|
| P64 |
High prevalence of
low testosterone in men with type 2 diabetes and an association with glycaemic control and
obesity |
|
Kapoor D, Aldred H, Channer KS & Jones TH |
|
|
| P65 |
Leptin increases
lipid peroxidation in the mouse brain |
|
Kutlu S, Canpolat S, Yasar A, Tuzcu M, Aydin M & Baydas
G |
|
|
| P66 |
Testosterone-induced
vasodilatation of isolated human mesenteric and pulmonary resistance arteries is
independent of the vascular endothelium |
|
Jones RD, Rowell KO, Pugh PJ, Shorthouse AJ, Adam IA,
Vaughan R, Rocco G, Hopkinson DN, Channer KS & Jones TH |
|
|
| P67 |
Evaluation of the
in-house radioimmunoassay method for peptide YY (PYY) |
|
Vincent RP, le Roux CW, Ghatei MA & Bloom SR |
|
|
| P68 |
Diastolic blood
pressure, waist circumference and cardiovascular disease in patients with obesity and type
2 diabetes |
|
Tuthill A, Tuthill V, Barrett C, McKenna M, O'Shea D &
McKenna TJ |
|
|
| P69 |
Diabetes risk in
Turner syndrome - a unique metabolic defect? |
|
Ostberg JE, Attar J, Mohamed-Ali V & Conway GS |
|
|
| P70 |
The metabolic
syndrome is common in type 2 but uncommon in type 1 diabetes mellitus |
|
Al-Saraj F, McDermott JH, McAteer S, Ali M,Tormey W &
Sreenan S |
|
|
| P71 |
Diabetes knowledge
deficits in adolescents and young adults with type 1 diabetes mellitus |
|
Khamis A, Hoashi S, Duffy G, Forde R, Vizzard N, Keenan P,
Cregan D, Firth RGR & Kinsley BT |
|
|
| P72 |
Maternal serum hCG
binding to immobilised wheat germ agglutinin in women with and without type 1 diabetes
mellitus |
|
Nayar R, Harris J, Marley L & Chapman J |
|
|
| P73 |
A comparison of the
impact of exercise in Asian and Caucasian women with polycystic ovary syndrome |
|
Banerjee A, Bano G & Kaushal R |
|
|
| P74 |
Exercise instruction
in patients with type 2 diabetes and obesity: a randomised controlled trial |
|
Tuthill A, Quinn A, McColgan D, McKenna M,O'Shea D &
McKenna TJ |
|
|
| P75 |
Characteristics and
outcome of severe hyponatraemia - a case control study |
|
Gill GV, Huda MSB, Wile D, Boyd A, Skagen K, Watson ID
& van Heynigen C |
|
|
| Endocrine
tumours and neoplasia |
| P76 |
Galectin-3 staining
of benign and malignant thyroid lesions - is it a useful diagnostic tool? |
|
Davies R, Barakat M, Meeran K & Dina R |
|
|
| P77 |
A case of severe
Cushing's disease in a treated non-functioning pituitary adenoma with difficult medical
management |
|
Akber M, Muza TR & Clayton RN |
|
|
| P78 |
Proliferation of
colon cancer cell line and parathyroid hormone-related peptide gene |
|
Alokail MS |
|
|
| P79 |
Is there an
ultra-short loop feedback of ACTH on itself? |
|
Sharma M, Nanzer AM, Morris DG, Adams EF, Korbonits M &
Grossman AB |
|
|
| P80 |
FSH-secreting
pituitary gonadotroph adenoma producing ovarian hyperstimulation |
|
Norris AJ, Hay C, Wilding M, McDowell G, Laing I, Holland
JP, McNeilly JR, McNeilly AS & Davis JRE |
|
|
| P81 |
Deacetylating agents
as mediators of iodide uptake and efflux in thyroid and breast |
|
Clarke C, Burbridge E & Smyth PPA |
|
|
| P82 |
Over-expression and
over-activation of protein kinase B/Akt in human pituitary tumours |
|
Musat M, Korbonits M, Kola B, Nanzer A, Morris DG,
Coculescu M & Grossman AB |
|
|
| P83 |
An audit of
acromegaly in North-East Scotland: increased use of medical therapy enables preservation
of pituitary function |
|
Viswanath AK, Booth SA, Abraham P & Bevan JS |
|
|
| P84 |
The cyclin E
specific F-box protein archipelago is over-expressed in pituitary tumours |
|
Morris DG, Bonner SE, Korbonits M & Grossman AB |
|
|
| P85 |
Urinary free
metadrenalines provide the best diagnostic biochemical test for phaeochromocytoma;
experience in a tertiary care centre |
|
Boyle JG, Davidson DF & Connell JMC |
|
|
| P86 |
A clinic for
multiple endocrine neoplasia highlights needs for greater family awareness of type 1 MEN
and for genetic testing of other family members |
|
Pinkney JH, MacFarlane IA, Ellard S & Cave-Bigley D |
|
|
| P87 |
Association between
serum insulin-like growth factor-I and serum growth hormone levels across an oral glucose
tolerance test in assessing disease activity in acromegaly |
|
Ayuk J, Stewart SE, Sheppard MC & Stewart PM |
|
|
| P88 |
Ovarian stromal
luteoma - a rare cause of postmenopausal virilization diagnosed by selective ovarian
venous sampling |
|
Nag S, Cruickshank D, Jackson T, Leen B & Kelly W |
|
|
| P89 |
The GnRH test in the
assessment of patients with pituitary and parapituitary lesions. Results of a 5-year
retrospective study |
|
Chammas NK, Chambers S & Harris PE |
|
|
| P90 |
Adrenal
incidentalomas and insulin resistance - a simple coincidence or a complex syndrome? |
|
Zieleniewski W |
|
|
| P91 |
Should post
hypophysectomy patients be discharged on steroids? The use of 0900h-cortisol measurements
as a screening test for pituitary-adrenal dysfunction |
|
Walker JN, Nickerson E, Gardner SG, Shine B, Turner HE
& Wass JAH |
|
|
| P92 |
Inhibition of cell
proliferation, but lack of antiangiogenic effect on GH-secreting pituitary adenomas
treated with Lanreotide |
|
Garcia de la Torre N, Sullivan N, Fazal-Sanderson V, Nagy
Z, Wass JAH, Ansorge O & Turner HE |
|
|
| P93 |
A new operation for
adrenal pathology: laparoscopically-assisted mini-adrenalectomy |
|
Abdel-Rahamn AT, Laban CA, Besser GM, Monson JP, Grossman
AB, Savage MO, Jenkins PJ, Drake WM, Chew SL, Ashby M & Carpenter R |
|
|
| P94 |
Somatostatin and
VEGF expression within the larynx |
|
Bedford KJ, MacDonald AW, Condon L, Stafford N & Atkin
SL |
|
|
| P95 |
The effects of
surgery and tamoxifen on serum IGF-I and IGFBP-3 levels in breast cancer |
|
McVittie CJ, McCarthy K, Laban CA, Miraki-Moud F,
Camacho-Hubner C, Bustin SA, Carpenter R & Jenkins PJ |
|
|
| P96 |
Results of different
primary treatment procedures for acromegalic patients |
|
Ozbey N, Gjergji D, Sertkaya A, Kurt R & Molvalilar S |
|
|
| P97 |
Transcriptional
silencing of the IGF-I receptor inhibits proliferation of MCF-7 breast cancer cells |
|
McVittie CJ, Ogunkolade W, Khalaf S, Bustin SA, Carpenter R
& Jenkins PJ |
|
|
| P98 |
Diagnosis - 'query
acromegaly' |
|
Hordern SVM, Banu G & Nussey SS |
|
|
| P99 |
Factors determining
remission of microprolactinomas after dopamine agonist withdrawal |
|
Powrie JK & Athauda NB |
|
|
| P100 |
Pituitary tumor
transforming gene (PTTG) regulates downstream angiogenic genes in thyroid cells |
|
Kim DS, Boelaert K, Stratford AL, Eggo MC, Watkinson JC,
Gittoes NJL, Franklyn JA & McCabe CJ |
|
|
| P101 |
Clinical studies of
patients with neuroendocrine tumours (NETs) |
|
Ali A, Richards D, Thakker RV & Hammersley MS |
|
|
| P102 |
IGF-I and IGFBP-3
mRNA expression in tamoxifen-resistant, recurrent breast cancers |
|
McCarthy K, Laban CA, McVittie CJ, Ogunkolade WB, Khalaf S,
Bustin SA, Carpenter R & Jenkins PJ |
|
|
| P103 |
IGF-I and IGFBP-3
mRNA expression in tamoxifen-resistant, recurrent breast cancers |
|
McCarthy K, Laban CA, McVittie C, Ogunkolade WB, Khalaf S,
Bustin SA, Carpenter R & Jenkins PJ |
|
|
| P104 |
A somatostatin
analogue and octreotide exert anti-proliferative effects on colonic cancer cells |
|
Khalaf S, Bailey F, Davies D, Ogunkolade BW, Kelly P,
McCarthy K, Laban C, Bustin SA & Jenkins PJ |
|
|
| P105 |
Imbalance between
separase and securin levels in thyroid and other malignancies |
|
Khanim FL, Parmley JL, Boelaert K, Stratford AL, Manners A,
Hodges N, McCabe CJ, Gittoes NJL & Franklyn JA |
|
|
| P106 |
The effects of
ghrelin on IGF-I expression in normal and malignant breast tissue explants |
|
Laban CA, Edwards C, Seb Gupta P, McCarthy K, Ogunkolade
BW, Bustin SA, Edwards R, Carpenter R & Jenkins PJ |
|
|
| P107 |
Prevalence of
hypopituitarism in patients with prolactin-secreting pituitary microadenomas |
|
Behan LA, Seoighe D, Agha A, Sherlock M, Ryan J, Rogers B
& Thompson CJ |
|
|
| P108 |
Systematic dose
extension of octreotide LAR - the importance of individual tailoring of treatment |
|
Thornton-Jones VA, Wass JAH & Turner HE |
|
|
| P109 |
Investigation into
the efficacy of routine octreotide scanning in post-operative acromegalics with refractory
disease |
|
Creely SJ, Varma TR & Vora J |
|
|
| P110 |
Octreotide
dependency: a cautionary tale |
|
Levy MJ & Goadsby PJ |
|
|
| P111 |
Expression of SSTR
subtypes (1-5) in normal and malignant colonic tissue |
|
Ogunkolade BW, Kelly PD, Fairclough PD, Khalaf S, Bustin SA
& Jenkins PJ |
|
|
| P112 |
Metastatic
glucagonoma de-differentiated to an insulinoma: response to embolization |
|
Dhillo WS, Meeran K & Todd JF |
|
|
| P113 |
Long acting
somatostatin analogues administered by practice nurses: an audit |
|
Fazal-Sanderson V, Thornton-Jones VA, Wass JAH & Turner
HE |
|
|
| P114 |
Long-term remission
following withdrawal of dopamine agonist therapy in subjects with microprolactinomas |
|
Biswas M, Smith J, Jadon D, McEwan P, Rees DA, Evans LM,
Scanlon MF & Davies JS |
|
|
| P115 |
The effects of
pituitary tumours on cognitive function |
|
Treece KA, Wass JA, Lincoln NB & Page RCL |
|
|
| P116 |
Novel actions of the
anti-estrogen faslodex at the estrogen receptor |
|
Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ &
Young LS |
|
|
| P117 |
Managing
prolactinomas: our experience at Preston |
|
Banerjee M, Myers M & Vice PA |
|
|
| P118 |
Expression and
localisation of BAD and Akt in human breast cancer cell lines pre- and post- irradiation |
|
Al-Bazz Y, Corke KP, Dobson PRM, Underwood JCE & Brown
BL |
|
|
| P119 |
Bilateral
laparoscopic adrenalectomy for ACTH-dependent Cushing's syndrome |
|
Newell-Price J, Gandhi A & Harrison BJ |
|
|
| P120 |
BIM-23244, a
somatostatin analogue with high affinity for somatostatin receptors 2 and 5, inhibits
endothelial proliferation in vitro |
|
Adams RL, Adams IP, Zhong W, Lindow SW & Atkin SL |
|
|
| P121 |
Discrepancies
between current consensus criteria for cure after transsphenoidal surgery for acromegaly |
|
Petakov MS, Djurovic M, Miljic D, Doknic M, Pekic S,
Popovic V & Damjanovic S |
|
|
| P122 |
Retrospective audit
of bilateral adrenalectomies with reference to the occurrence of Nelson's syndrome |
|
Green AJ, Barakat MT, Lynn JA & Meeran K |
|
|
| P123 |
Parathyroid imaging:
which modality best informs surgical treatment? |
|
Shaafi KO, West TET & Walsh T |
|
|
| P124 |
The efficacy of an
octreotide test dose to predict the outcome of treatment for acromegaly with somatostatin
LAR |
|
Claridge AG, Shakoor SKA & Trainer PJ |
|
|
| P125 |
The changing
patterns of presentation and treatment of acromegaly in the UK as reflected by the UK
National Acromegaly Database |
|
Wass JAH, Carson MN & Bates PR |
|
|
| P126 |
Improved quality of
life (QOL) with normalisation of IGF-I in patients with acromegaly |
|
Paisley AN, Rowles SV, Roberts ME, Lee C & Trainer PJ |
|
|
| P127 |
24-Hour ambulatory
blood pressure monitoring (ABPM) in patients with acromegaly and the value of clinic blood
pressure measurements |
|
Paisley AN, Roberts ME, Heagerty AM & Trainer PJ |
|
|
| P128 |
Regional variations
in colonic neoplasia in acromegaly |
|
Ahmad B, Fazal-Sanderson V, Jewell DP, Warren B, Turner HE
& Wass JAH |
|
|
| Growth and
development |
| P129 |
The effect of
nutritional deprivation in late gestation on uncoupling protein-2 mRNA abundance in the
ovine neonatal lung |
|
Gnanalingham MG, Mostyn A, Symonds ME & Stephenson TJ |
|
|
| P130 |
Possible factors
determining individual sensitivity to GH replacement therapy; a KIMS database analysis |
|
Monson J, Lundberg M, Bouloux PMG, Bevan JS, Svensson J,
Koltowska-Häggström M & Finer N |
|
|
| P131 |
Do prolonged courses
of testosterone affect final height in extreme maturational delay? |
|
Lee R & Butler G |
|
|
| P132 |
The hydration
fraction of lean body mass (LBM) does not change during six months physiological GH
replacement in adults with severe GHD |
|
Mukherjee A, Adams JE, Smethurst L & Shalet SM |
|
|
| P133 |
The relationship
between maternal thyroid status in the antenatal period and new born growth measurements:
a cohort study |
|
Hindmarsh P, Franklyn JA, Clark P, Geary M, Rodeck C &
Kilby MD |
|
|
| P134 |
Quality of life
(QOL) improvement, during physiological GH replacement in severely GHD adults, is not
explained by favourable changes in body composition |
|
Mukherjee A, Adams JE, Smethurst L & Shalet SM |
|
|
| P135 |
Leptin and leptin
receptor localisation in endocrine glands of fetal sheep |
|
O'Connor DM, Wooding FBP, Hoggard N, Forhead AJ &
Fowden AL |
|
|
| P136 |
The value of the TRH
test in the assessment of hypothalamic-pituitary disorders in children |
|
Tatnall S, Slim B, Kumar K, Patel L, Hall CM, Price DA
& Clayton PE |
|
|
| P137 |
Frequency of single
nucleotide polymorphisms in the GHRH receptor gene in short children |
|
Smith KG, Gueorguiev M, Adams EF, Mein CA, Johnston LB,
Bonner SE, Froguel P, Savage MO, Grossman AB & Korbonits M |
|
|
| P138 |
A dominant negative
thyroid hormone receptor (TR) beta1 mutant enhances N-Tera-2 (NT2) cell proliferation |
|
Chan SY, McCabe CJ, Franklyn JA & Kilby MD |
|
|
| P139 |
Transdermal
testosterone application: pharmacokinetics and effects on pubertal status, short-term
growth and bone turnover |
|
Ahmed SF, Mayo A, MacIntyre H & Wallace AM |
|
|
| P140 |
Long-term
association of the Y chromosome and blood pressure in boys at the pre- and post-pubertal
periods |
|
Charchar FJ, Shankar R, Eckert GJ, Tomaszewski M,
Dominiczak AF & Pratt JH |
|
|
| P141 |
Growth hormone
replacement reduces circulating inflammatory markers, blood pressure and large artery
compliance but does not affect resistance artery function in adult hypopituitary patients |
|
McCallum RW, Spiers A, Sattar N, Petrie JR, Dominiczak AF
& Connell JMC |
|
|
| P142 |
Regulation of the
growth hormone (GH) and insulin-like growth factor-I (IGF-I) paracrine pathway by thyroid
hormone (T3) during bone development |
|
Sriskantharajah S, O'Shea PJ, Yao H, Suzuki H, Cheng SY
& Williams GR |
|
|
| P143 |
Pregnancy-induced
plasticity in rat pituitary: a morphological and endocrine study of somatotroph and
lactotroph function |
|
El-Kasti MM, Christian HC, Huerta I, Hill N, Matthews DR
& Wells T |
|
|
| P144 |
Gene expression in
peripheral blood mononuclear cells: the effect of GH in a GH-deficient child |
|
Whatmore AJ, Hayes A, Patel L & Clayton PE |
|
|
| Neuroendocrinology
and behaviour |
| P145 |
The insulin
tolerance test (ITT) in clinical practice: the experience of a busy pituitary unit |
|
Liew A, Agha A, Finucane F, Thornton E, Rogers B, Tormey W
& Thompson CJ |
|
|
| P146 |
Cardiovascular risk
burden in adult patients with hypopituitarism |
|
Kyaw Tun T, Agha A, Muigai N, Al-Sahli W, Rogers B, Tormey
W & Thompson CJ |
|
|
| P147 |
Incorporating social
preferences in the measurement of QoL outcomes in growth hormone deficiency (GHD) in
adults |
|
Kind P & Koltowska-Häggström M |
|
|
| P148 |
Neuroendocrine
abnormalities in the acute phase of traumatic brain injury |
|
Rogers B, Agha A, Mylotte D, Tormey W, Phillips J &
Thompson CJ |
|
|
| P149 |
Investigating the
potential role of melanocortin receptor 5 in the rodent adrenal gland |
|
Kosti O, Renshaw D, Harrold J, Cone R & Hinson J |
|
|
| P150 |
Quality of life
deficit in hypopituitary adults with growth hormone deficiency (GHD): comparison of
age-sex matched patient data and a UK population survey |
|
Koltowska-Häggström M, Monson JP, Hennessy S, Mattsson A
& Kind P |
|
|
| P151 |
Downward resetting
of the osmotic threshold for thirst in patients with syndrome of inappropriate
antidiuretic hormone |
|
Smith D, Moore K, Tormey W, Baylis PH & Thompson CJ |
|
|
| P152 |
Nephrogenic diabetes
insipidus in the mouse does not deplete vasopressin neurons or activate oxytocin neurons |
|
Morris JF, Epton MJ & Jenkins D |
|
|
| P153 |
Comparison of
anterior pituitary annexin 1 expression in male/female and old/young Long Evans and
Brattleboro rats |
|
Davies E, Christian HC, Buckingham JC & Morris JF |
|
|
| P154 |
Prevalence of
hypopituitarism in survivors of traumatic brain injury |
|
Agha A, Rogers B, Tormey W, Phillips J & Thompson CJ |
|
|
| P155 |
The effect of
oestrogen replacement therapy (ORT) on growth hormone (GH) dose; KIMS database
perspective |
|
Mah PM, Ross RJM, Jönsson P, Feldt-Rasmussen
U, Koltowska-Häggström M & Webster J |
|
|
| P156 |
Metastatic
glucagonoma transforming to an insulinoma |
|
Byard A, Rangan S, Dixon A, Kos K, Edavalath M, Buch HN
& Singh BM |
|
|
| P157 |
Investigation of the
hypothalamo-pituitary-adrenal axis in patients with irritable bowel syndrome |
|
Baskol M, Gokce C, Yucesoy M & Kelestimur F |
|
|
| P158 |
DNA microarray
analysis of NECA action in a pituitary folliculostellate cell line |
|
Rees DA, Scanlon MF & Ham J |
|
|
| P159 |
Imaging of the
pituitary is indicated in marginal hyperprolactinaemia (<1000
milliunits per litre) to detect microadenoma |
|
Shore HCA, Karavitaki N, Turner HE & Wass JAH |
|
|
| P160 |
Effects of melatonin
on catecholaminergic neurotransmitters in brain areas regulating food intake in the male
rat |
|
Canpolat S, Sandal S, Kutlu S, Aydin M, Yilmaz B &
Kelestimur H |
|
|
| P161 |
The acute octreotide
suppression test is useful in predicting long-term responses to depot somatostatin
analogue injections in patients with active acromegaly |
|
Botusan I, Karavitaki N, Radian S, Turner HE & Wass JAH |
|
|
| P162 |
Effects of melatonin
on the regulation of leptin production in rat anterior pituitary cells |
|
Kus I, Sarsilmaz M, Colakoglu N, Kukner A, Ozen OA, Yilmaz
B & Kelestimur H |
|
|
| P163 |
Primary therapy with
somatostatin analogues in acromegaly does not restore orderly GH secretion |
|
Parkinson C, Darzy K, Peacey SR, Thorner MO, Veldhuis JD,
Trainer PJ & Shalet SM |
|
|
| P164 |
Down-regulation of
neurotrophin receptor expression limits the regenerative potential of injured CNS neurons |
|
Brown ER, Berry M & Logan A |
|
|
| P165 |
Functional
interactions between anosmin-1, heparan sulphate and urokinase-type plasminogen activator
and the pathogenesis of X-linked Kallmann's Syndrome |
|
Hu Y, Gonzalez-Martinez D & Bouloux P |
|
|
| P166 |
Are cortisol
responses to psychological stress related to size at birth in humans? |
|
Ward AMV, Moore VM, Steptoe A, Robinson JS & Phillips
DIW |
|
|
| P167 |
Addition of dopamine
agonists to somatostatin analogue therapy improves biochemical control of acromegaly |
|
Selverajah D, Webster J, Ross RJM & Newell-Price J |
|
|
| P168 |
Variability in GH
assays undermines the value of consensus criteria for the diagnosis of adult GH deficiency
and acromegaly |
|
Pokrajac-Simeunovic A, Wieringa GE, Ellis AK & Trainer
PJ |
|
|
| P169 |
The role of the
melanocortin 5 receptor in the hypothalamic regulation of appetite and pituitary function |
|
Sajedi A, Abbott CR, Small CJ, Haskell-Luevano C, Ghatei MA
& Bloom SR |
|
|
| Reproduction |
| P170 |
Leptin, inhibin B
and LH levels in patients with anorexia nervosa |
|
Djurovic M, Pekic S, Cetkovic A, Doknic M, Petakov M,
Damjanovic S, Zivkovic V, Dieguez C, Casanueva F & Popovic V |
|
|
| P171 |
Regulation of ovine
placentome morphology by cortisol in late gestation |
|
Ward JW & Fowden AL |
|
|
| P172 |
The effect of
insulin-like growth factor I (IGF-I) on initiation of follicle growth in normal and
polycystic ovaries in vitro |
|
Stubbs S, Zachery-Jennings C, Margara R, Trew GH, Lavery S,
Stark J, Hardy K & Franks S |
|
|
| P173 |
Specificity and
clinical utility of methods for the detection of macroprolactin |
|
Smith TP, Gibney J, Kavanagh L, Fahie-Wilson MN &
McKenna TJ |
|
|
| P174 |
New approach in
treatment of hyperandrogenism with triiodothyronine |
|
Kazanavicius G |
|
|
| P175 |
Effect of
supplementing the maternal diet with excess energy during late gestation on body fat
deposition, reproductive performance and plasma insulin concentration in pigs |
|
Laws J, Perkins KS, Litten JC, Corson AM & Clarke L |
|
|
| P176 |
The effects of
thyroid hormone on cytokine-induced proliferation in human trophoblast cells |
|
Barber KJ, Khanim FL, McCabe CJ, Bulmer JN, Whitley GS,
Franklyn JA & Kilby MD |
|
|
| P177 |
Oral tibolone
combined with testosterone as a potential male contraceptive: pharmacodynamic study
examining additive effects in suppression of pituitary-testicular axis |
|
Oxynos C & Wu FCW |
|
|
| P178 |
Routine screening
for macroprolactin |
|
Gibney J, Smith TP & McKenna TJ |
|
|
| P179 |
Microarray studies
of human ovarian surface epithelium exposed to an inflammatory stimulus |
|
Rae MT, Ross A, Niven D, Critchley HOD, Ghazal P, Lathe R
& Hillier SG |
|
|
| P180 |
Peroxisome
proliferator-activated receptor-gamma (PPARgamma) agonists increase glucose metabolism in
a human granulosa cell line (HGL-5) |
|
Berdiaki A, Chatterjee VKK, Rainey WE & Franks S |
|
|
| P181 |
The CAM technique
and follicle development |
|
Qureshi AI, Bano G, Whitehead S, Nussey SS & Mason HD |
|
|
| P182 |
Paint thinner
exposure inhibits testosterone synthesis and secretion in a reversible manner in the rat |
|
Yilmaz B, Akpolat N, Canpolat S, Sandal S, Kutlu S, Ilhan N
& Kelestimur H |
|
|
| P183 |
Ultrastructural and
immunohistochemical examination of effects of leptin on testis in mice |
|
Kus I, Canpolat S, Akpolat N, Ozogul C, Yilmaz B, Sarsilmaz
M & Kelestimur H |
|
|
| P184 |
Stimulatory effects
of ghrelin on spontaneous contractions in the rat myometrium |
|
Kutlu S, Dayangac A, Ozcan M, Konar V, Kumru S & Ayar A |
|
|
| P185 |
The expression of
somatostatin receptors in human granulosa cells |
|
Adams IP, Staunton B, Gilson J, Adams RL, Robinson J &
Atkin SL |
|
|
| P186 |
Anti-Müllerian
hormone (AMH) protein expression in normal and polycystic human ovaries |
|
Stubbs S, Webber L, Flanagan A, Da Silva-Buttkus P, Themmen
APN, Visser JA, Groome NP, Hardy K & Franks S |
|
|
| P187 |
Effects of oral
nomegestrol acetate, a 19 norprogesterone-derived progestin on the reproductive axis and
lipids in men |
|
Hay CJ & Wu FCW |
|
|
| P188 |
Follow up of women
with Turner's syndrome in an adult endocrine clinic |
|
Ghosh S, Hussein NM, Gibson C, Ray DW, Wu FC & Davis
JRE |
|
|
| P189 |
TGFbeta signaling pathways in LHRH neurons |
|
Galbiati M, Saredi S & Melcangi RC |
|
|
| P190 |
Müllerian inhibiting
substance is elevated in obese women with PCOS and is suppressed by metformin
treatment |
|
Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J,
Sattar N & Seifer DB |
|
|
| P191 |
Protein kinase
(PKA)-independent but cAMP-dependent regulation of progesterone secretion by luteinizing
human granulosa cells |
|
Chin EC & Abayasekara DRE |
|
|
| P192 |
Intramuscular
testosterone (T) undecanaote for the treatment of male hypogonadism: a parallel-group
randomised open-label pharmacokinetic study |
|
Hay CJ & Wu FCW |
|
|
| P193 |
Neurokinin B-like
immunoreactivity can be detected in peripheral tissues in the non-pregnant rat |
|
Brayley KJ & Bell NJ |
|
|
| P194 |
Biochemical evidence
for follicular maturation (1): changes of inhibins and activin-A levels in follicular
fluid from matched follicles |
|
Wen XU, Tozer A, Butler SA & Iles RK |
|
|
| P195 |
Analysis of hCG beta
core fragment glycosylation in normal and aberrant pregnancy by matrix-assisted laser
desorption/ionisation time-of-flight mass spectrometry |
|
Malatos S, Jacoby ES, Juneja NA, Butler SA, Kicman AT &
Iles RK |
|
|
| P196 |
Biochemical evidence
for follicular maturation (2): production of progesterone, inhibins and activin-A by
granulosa cells from size matched follicles |
|
Wen XS, Tozer AJ, Butler SA & Iles RK |
|
|
| P197 |
Clinical
interpretation of macroprolactin reports |
|
Moyes V, Fahie-Wilson MN & Ahlqvist JAO |
|
|
| Steroids |
| P198 |
Conventional
corticosteroid replacement therapy may overtreat adult hypopituitary patients with partial
ACTH deficiency |
|
Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W
& Thompson CJ |
|
|
| P199 |
Glucocorticoids
contribute to the heritability of leptin in Scottish adult female twins |
|
Wallace AM, Banfield E, Ingram M, Swan L, Hillis WS &
Connell JMC |
|
|
| P200 |
Patients' knowledge
and satisfaction on the management of steroid replacement therapy |
|
Breen LA |
|
|
| P201 |
The origin of
18-hydroxycortisol and 18-oxocortisol in man |
|
Freel EM, Shakerdi L, Wallace AM, Ingram M, Fraser R &
Connell JMC |
|
|
| P202 |
Sweat patch cortisol
- a new screen for Cushing's syndrome |
|
Prunty H, Andrews K, Reddy-Kolanu G, Quinlan P & Wood
PJ |
|
|
| P203 |
Dehydroepiandrosterone
sulphate (DHEAS) inhibits growth of human vascular endothelial cells |
|
Hinson JP, Renshaw D, Vakharia K & King PJ |
|
|
| P204 |
Inhibition of
steroid 5beta-reductase by bile acids |
|
McNeilly AD, Livingstone DEW, Walker BR & Andrew R |
|
|
| P205 |
Adequacy of patient
understanding about glucocorticoid replacement |
|
Gibson CM, Brough R, Ray DW, Wu FCW & Davis JRE |
|
|
| P206 |
Regulation of
11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat
adrenal gland and central nervous system by ACTH and dexamethasone |
|
Ye P, Kenyon CJ, Nichol K, MacKenzie SM, Fraser R, Seckl
JR, Connell JMC & Davies E |
|
|
| P207 |
Local inflammation
activates the renal vitamin D hormonal system in human kidneys |
|
Zehnder D, Quinkler M, Lepenies J, Eardley K, Hughes S,
Cockwell P, Stewart PM & Hewison M |
|
|
| P208 |
The testicular
feminised mouse: physiological testosterone replacement |
|
Nettleship JE, Biggins CM, Jones RD, English KM, Channer KS
& Jones TH |
|
|
| P209 |
The effect of
adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene
expression in the hippocampus |
|
Ye P, Kenyon CJ, Nichol K, MacKenzie SM, Fraser R, Seckl
JR, Connell JMC & Davies E |
|
|
| P210 |
Quantitative
analysis of plasma 17-hydroxyprogesterone using isotope dilution mass spectrometry |
|
Honour JW, Thorpe E & Hodkinson R |
|
|
| P211 |
Spironolactone
interference in the immunoassay of androstenedione |
|
Honour JW, Tsilchorozidou T & Conway GS |
|
|
| P212 |
Role of PPAR-gamma
receptor agonist therapy in two patients with newly diagnosed pituitary-dependent
Cushing's syndrom |
|
Hull SSA, Sheridan B & Atkinson AB |
|
|
| P213 |
Local regeneration
of glucocorticoids by 11betaHSD-1 within the vessel wall modulates angiogenesis |
|
Small GR, Dover AR, Hadoke PWF & Walker BR |
|
|
| P214 |
Lipopolysaccharide
(LPS) stimulates cortisol secretion via toll-like receptors and COX-2 activation |
|
Vakharia K, Renshaw D & Hinson JP |
|
|
| P215 |
An AP-1-like site is
required for basal activity of the murine ACTH receptor (MC2-R) promoter in Y1 cells |
|
King PJ & Clark AJL |
|
|
| P216 |
The inhibition of
human hair growth by 17beta-oestradiol using whole follicle organ cultures |
|
Nelson LD, Messenger AG, Karoo R & Thornton MJ |
|
|
| P217 |
Molecular basis of a
new form of congenital adrenal hyperplasia |
|
Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F,
Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM & Shackleton
CHL |
|
|
| P218 |
The impact of
endogenous cortisone on bone and fat: demonstration of in vivo 11beta-hydroxysteroid
dehydrogenase type 1 activity |
|
Cooper MS, Syddall HE, Tomlinson JW, Eastell R, Wood PJ,
Stewart PM, Cooper C & Dennison EM |
|
|
| P219 |
Hexose 6-phosphate
dehydrogenase expression confers reductase activity upon 11 beta-HSD1 in adipose tissue |
|
Bujalska IJ, Tomlinson JW, Draper N, Walker EA &
Stewart PM |
|
|
| P220 |
Secretogogues induce
transcription factor SF-1 and co-activator SRC-1 activity in the human adrenal gland |
|
Kelly SN, McKenna TJ & Young LS |
|
|
| P221 |
Mineralocorticoid
replacement in patients with primary hypoadrenalism; does plasma renin concentration help
in practice? |
|
Anthony S, Madathil A, Smith J & Chapman J |
|
|
| P222 |
A model for
evaluating 11beta-hydroxysteroid dehydrogenase type 1 activity in ocular and orbital
tissues |
|
Walker EA, Tomlinson JW, Hughes SV, Wood PJ, Murray PI,
Stewart PM & Rauz S |
|
|
| P223 |
11ß-hydroxysteroid
dehydrogenase type 1 and the production of cerebrospinal fluid |
|
Rauz S, Walker EA, Tomlinson JW, Hughes SV, Wood PJ,
Stewart PM & Murray PI |
|
|
| P224 |
Reproducibility of
cortisol day curve in monitoring patients on long-term hydrocortisone replacement therapy |
|
Shakoor SKA, Roberts M, Shalet SM & Trainer PJ |
|
|
| P225 |
Gene expression
responses induced in kidney by aldosterone excess and salt |
|
Marshall E, Dickenson P, Forster T, Roy D, Kenyon CJ &
Brown RW |
|
|
| Thyroid |
| P226 |
Outcome of atrial
fibrillation complicating hyperthyroidism |
|
Osman F, Daykin J, Sheppard MC, Gammage MD & Franklyn
JA |
|
|
| P227 |
No association of a
polymorphism in the kozak sequence of the CD40 gene and Graves' disease in a UK Caucasian
population |
|
Foxall H, Heward JM, Franklyn JA & Gough SC |
|
|
| P228 |
Congenital
hypothyroidism (CH) in the United Arab Emirates (UAE) - past, present and future |
|
Hardy JD, Hosani H, Salah M, Zayed R, Dhatt G & Doss I |
|
|
| P229 |
Twenty-four hour
hormone profiles of TSH, free T3 and free T4 in hypothyroid patients
on combined T3T4 therapy |
|
Siddique H, Saravanan P, Simmons DJ, Greenwood R, Peters TJ
& Dayan CM |
|
|
| P230 |
Thyroid hormones and
TPO-antibodies in the cord blood of newborns |
|
Bohnet HG, Narwak M, Ebert P & Peters N |
|
|
| P231 |
Pretibial myxoedema
as the first manifestation of Graves' disease |
|
Watt AJ, Vaidya B & MacLeod KM |
|
|
| P232 |
Thyroxine
replacement monitoring using a computerised register: the North Trent experience |
|
Lee S, Stevens V, Parramore A, Weetman AP & Allahabadia
A |
|
|
| P233 |
Estimators of
number- and volume-weighted mean volume of colloid in the thyroid gland of rats |
|
Hartoft-Nielsen M-L, Rasmussen AK, Feldt-Rasmussen U,
Buschard K & Bock T |
|
|
| P234 |
Adjunctive lithium
improves outcome in patients given radioiodine for hyperthyroidism |
|
Murphy E, Winstanley G, Frank J & Meeran K |
|
|
| P235 |
Evaluation of
thyroid function in patients with chronic active HCV and HBV hepatitis treated with
interferon-alpha |
|
Esfahanian F, Alavian M & Ziaee A |
|
|
| P236 |
Hypothyroidism is
less frequent following radioactive iodine treatment for toxic nodular goitre than
Graves' disease |
|
Adamali HI, Gibney J & McKenna TJ |
|
|
| P237 |
Seaweed as a model
for iodide uptake and retention in the thyroid |
|
Burbridge E, Clarke C & Smyth PPA |
|
|
| P238 |
Multiple thyroid
tumours |
|
Qureshi AI, Bano G & Nussey SS |
|
|
| P239 |
Specific effect of
thyrotropin on thyroglobulin and on the polypeptides distribution in cultured human
thyroid cells |
|
Milicevic Z & Ciric J |
|
|
| P240 |
Defining
aetiological variants within the HLA class II region that lead to the development of
Graves' disease |
|
Simmonds MJ, Heward JM, Howson JMM, Cordell HJ, Walker N,
Todd JA, Franklyn JA & Gough SCL |
|
|
| P241 |
The evaluation of
arterial stiffness in subclinical hypothyroidism |
|
Owen PJD & Lazarus JH |
|
|
| P242 |
Premature birth and
fetal growth retardation in nonautoimmune hyperthyroidism due to activating thyrotropin
receptor gene mutation |
|
Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT
& Ellard S |
|
|
| P243 |
Controlled
anti-natal thyroid screening study (CATS) - early results |
|
Lazarus JH, Parkes AB, Taylor IL, Smyth PPA, John R &
Wald N |
|
|
| P244 |
The expression of
mRNA for thymidine kinase 1 (TK1), deoxycytidine kinase (dCK), and thymidine phosphorylase
(dThdPase) in the tissue of papillary thyroid carcinoma (PTC) and of medullary thyroid
carcinoma (MTC) in humans |
|
Karbownik M, Brzezianska E & Lewinski A |
|
|
| P245 |
Does thyroidectomy
exacerbate or relieve the throat symptoms of globus pharyngeus? |
|
England J, Hayworth D, Hayden A, Nadig S, Nix P & Atkin
SL |
|
|
| P246 |
Electrocardiographic
changes in patients with hypothyroidism |
|
Agarwal SC, Hira HS & Sibal L |
|
|
| P247 |
Regulation of the
angiopoietins in thyroid follicular cells |
|
Buchanan MA, Ramsden JD, Watkinson JC & Eggo MC |
|
|
| Clinical case reports |
| P248 |
X-linked
hypopituitarism: clinical and biochemical features of a rare cause of short stature |
|
Barber TM, Cheetham T & Ball SG |
|
|
| P249 |
Cocaine use a risk
factor for DKA |
|
Kashyap AS, Anand KP & Kashyap S |
|
|
| P250 |
Osteomalacia
precipitated by growth hormone treatment in the adult: increased bone turnover unmasking
occult vitamin D deficiency |
|
Abouglila K, Miller M & Ball SG |
|
|
| P251 |
Adrenal
insufficiency as the second clinical manifestation of the primary antiphospholipid
antibody syndrome |
|
Abouglila K, James A, Stevenson M & Hanley J |
|
|
| P252 |
Paradoxical urine
and plasma cortisol response to dexamethasone: probable Carney Complex with micronodular
adrenal hyperplasia |
|
Raskauskiene D & Clayton RN |
|
|
| P253 |
Myocardial
infarction due to coronary artery spasm in a patient with thyrotoxicosis |
|
Srinivasan R, Sturrock NDC, Morris K & Patel K |
|
|
| P254 |
Puerperal
hypoglycaemia in a young woman with type 1 diabetes mellitus |
|
Moisey RS, Andrew J, Nagi DK & Jenkins RC |
|
|
| P255 |
Coeliac disease as a
cause for delayed presentation of hypopituitarism |
|
Moisey RS, Ajjan R, Spencer N, Sahay P, Nagi DK, Andrew J
& Jenkins RC |
|
|
| P256 |
Thyrotoxicosis due
to Graves' disease in a patient on immunosuppressive therapy for psoriasis |
|
Forbes MI, MacLeod K & Vaidya B |
|
|
| P257 |
Transformation of a
micro-prolactinoma to a macro-prolactinoma during pregnancy without symptoms or signs of
pituitary enlargement: two case reports |
|
Dixon AN, Rangan S & Singh BM |
|
|
| P258 |
Severe
hypercalcaemia in Graves' disease |
|
Murphy MS & Nolan JJ |
|
|
| P259 |
Diagnostic
difficulty in differentiating between meningioma and pituitary adenoma |
|
Hatfield ECI, Lewis DH, Powell M, Ng KL, Kong C &
Johnston C |
|
|
| P260 |
Pitfalls in the
management of hypocalcaemia: refractory hypocalcaemia after thyroidectomy not caused by
postoperative hypoparathyroidism |
|
Skowronska-Jozwiak E, Lewandowski KC & Lewinski A |
|
|
| P261 |
Hypothalamic
cavernous haemangioma presenting with hypothalamic syndrome and secondary hypogonadism |
|
Downward HS, Rowmanowski CAJ & Bennet WM |
|
|
| P262 |
Acquired von
Willebrand's disease secondary to autoimmune hypothyroidism |
|
Viswanath AK, Mayo A, King D & Bevan JS |
|
|
| P263 |
A case of the
pituitary resistance to thyroid hormone successfully treated with bromocriptine |
|
Zieleniewski W, Kolodziej-Maciejewska H & Krawczyk ZK |
|
|
| P264 |
Hyponatremia and
recurrent abdominal pain |
|
Prakash PK & Stephens WP |
|
|
| P265 |
Cushing's disease
and coexistent craniopharyngioma - report of a case |
|
Karavitaki N, Hull RP, Ansorge O, Brufani C & Wass JAH |
|
|
| P266 |
Is there an
association between serum calcium concentrations and endoscopic diagnosis in patients with
dyspeptic symptoms? |
|
Movva R, Alcolado R & Alcolado JC |
|
|
| P267 |
A vicious cycle of
profuse diarrhoea, hypokalaemic renal failure and elevated gut hormone levels unmasking a
neuroendocrine pancreatic tumour |
|
Yogarajah M, Ahmed A, Winocour PH, Katz J & Aldridge M |
|
|
| P268 |
The pituitary lesion
that escaped the knife |
|
Heald AH, Hughes D & Buckler H |
|
|
| P269 |
Primary and
secondary hypogonadism in systemic sarcoidosis: indications for corticosteroid therapy |
|
Rees DA, Mukherjee S, Dodds A, Rathbone N, Lane H, Peters
JR, Davies JS & Scanlon MF |
|
|
| P270 |
Truly rare - a true
hermaphrodite |
|
Arutchelvam V, Kelly WF & Wolstenholme J |
|
|
| P271 |
Normoprolactinaemic
galactorrhoea in a male-to-female transsexual |
|
Barber TM, Basu A, Rizvi K & Chapman J |
|
|
| P272 |
Myxoedema coma with
pericardial effusion and respiratory arrest in a 59-year-old woman |
|
Mackay EM, Kennedy A, Dalzell G & Atkinson AB |
|
|
| P273 |
Development of GH
secretion and malignant change in a giant prolactinoma |
|
Howell SJ, Parkington S, Roberts G & Vice PA |
|
|
| P274 |
Crooke Cell Adenoma:
case report of a rare but aggressive tumour |
|
O'Shea LA, Farrell MA, Phillips J, Kinsley BT & Firth
RG |
|
|
| P275 |
Bilateral
laparascopic adrenalectomy as a palliative procedure for resistant ectopic ACTH producing
small cell carcinoma of the lung: a case report |
|
Nayar R, Kierstan J & Perros P |
|
|
| P276 |
The evolution of
diabetes insipidus in a man with multiple pathology in the sacrum |
|
Rajeswaran C, Oxynos C & Belchetz PE |
|
|
| P277 |
A diagnostic
pitfall: concomitant occurrence of macroprolactinaemia and a non-secreting pituitary
adenoma |
|
Krishnan U, Qureshi MZ, Burrows J, Labib M & Fiad TM |
|
|
| P278 |
Primary
hypopituitarism as a first presentation of sarcoidosis - 2 case reports |
|
Galliford TM & Hopkins DFC |
|
|
| P279 |
A novel 17 alpha
hydroxylase mutation (CYP 17) associated with a pelvic germ cell tumour |
|
Brooke AM, Ahmad T, Taylor NF, Shepherd J, Lin L, Achermann
JC, Rumsbey G, Gore ME & Monson JP |
|
|
| P280 |
Surgical treatment
of children with neonatal severe hyperparathyroidism |
|
Kurzawinski TR, Fazel MZ, Spitz L, Waller S, Milroy E,
van'T Hoff W & Dattani M |
|
|
| P281 |
Recognition of Smith
Lemli Opitz syndrome by characteristic steroids |
|
Honour JW, Phillips I & Conway E |
|
|
| P282 |
Pituitary
sarcoidosis with disappearing mass: case report |
|
Oxynos C, Rajeswaran C & Belchetz PE |
|
|
| P283 |
A case of
undiagnosed multiple endocrine neoplasia type 2B (MEN 2B) |
|
Myint KS, Wiles A, Marker A, Jani P, Middleton S,
Chatterjee VKK & Gurnell M |
|
|
| P284 |
Late recovery of
pituitary function following traumatic brain injury |
|
Ryan J, Agha A, Sherlock M & Thompson CJ |
| |
|
| P285 |
Hypocalcaemia and
hypomagnesaemia as a complication of Cronkhite-Canada syndrome |
|
Lewandowski KC, Finan PJ, Cairns A & Orme SM |
|
|
| P286 |
Porphyria cutanea
tarda complicated by primary hepatocellular carcinoma |
|
Arutchelvam V, McCulloch A, Senadhira T & Nag S |
|
|
| P287 |
Post menopausal
virilisation |
|
Smeeton FJ, Bano G & Nussey SS |
|
|
| P288 |
Testosterone-replacement
stimulated hyperprolactinaemia |
|
Sodi R, Fikri R, Diver M, Ranganath L & Vora J |
|
|
| P289 |
A case of
non-classical 11-beta hydroxylase deficiency |
|
Freel EM, Wallace M, Fraser R, Davies E & Connell JMC |
|
|
| P290 |
Spontaneously
resolving hypopituitarism followed by primary adrenal lymphoma-related phenomena? |
|
Abdalla TME, Adams C, Wenham S, Williams G, Wayte A &
Wilton A |
|
|
| P291 |
A case of adrenal
failure secondary to metastasis from a breast angiosarcoma |
|
Shalet SR, Khan AN & Issa BG |
|
|
| P292 |
A case of severe
congenital adrenal hyperplasia treated successfully with laparoscopic bilateral
adrenalectomy |
|
Mullan K, Russell C, Dolan S, Sheridan B & Atkinson AB |
|
|
| P293 |
Ectopic pancreas
presenting as dyspepsia |
|
Kapoor D, Azmy M & Jones TH |
|
|
| P294 |
Ectopic ACTH
syndrome presenting with epistaxis and hypertension: a case report |
|
McLaughlin DM, Kassim SB, Leslie H & McCance DR |
|
|
| P295 |
Tuberculous
thyroiditis - a rare cause of hyperthyroidism |
|
Murphy MS, Keane J & Cullen MJ |
|
|
| P296 |
Multiple endocrine
disturbances in a 15-year-old girl with intranial tuberculomas |
|
Triantafyllidis G, Karakaidos D, Zosi P, Hatzigeorgiou G,
Kafalidis G, Theodoridis C & Karis C |
|
|
| P297 |
Gestational diabetes
insipidus, severe hypernatremia and hyperemesis gravidarum in a primigravid pregnancy |
|
Hoashi S, Margey R, Haroun A, Keatings VM & Firth RGR |
|
|
| P298 |
The use of
17-hydroxyprogesterone and short synacthen tests in patients diagnosed with polycystic
ovarian syndrome |
|
Rathbone N, Rees DA, Davies JS & Scanlon MF |
|
|
| P299 |
Human chorionic
gonadotrophin responsive adrenal cortical carcinoma and Cushing's syndrome in pregnancy |
|
Hoashi S, O'Connell J, Kelly SN, Young L, Fitzpatrick J,
O'Keane C & Kinsley BT |
|
|
| P300 |
Severe reactive
hypoglycaemia alleviated by acorbose administration |
|
Thomas CM, Ward AMV & Leatherdale BA |
|
|
| P301 |
Complete right vocal
cord paralysis: a very rare complication of radioiodine therapy for hyperthyroidism |
|
Beshyah SA, Al-Fallouji H & Neave F |
|
|
| P302 |
Radiotherapy is more
effective than growth hormone in treating haemangiopericytoma induced hypoglycaemia |
|
Soran H, Joseph F, Younis N & Scott A |
|
|
| P303 |
Short stature in
thalassemia major: multiple aetiologies |
|
Jha S, Bano G & Nussey SN |
|
|
| Clinical practice |
| P304 |
An audit to evaluate
the second radioiodine challenge scan in patients with thyroid cancer |
|
Batra R, Perros P, Fenwick J & Mallick U |
|
|
| P305 |
Audit of follow-up
for patients on long-term amiodarone and the incidence of amiodarone induced
thyrotoxicosis |
|
McCulloch AJ, Joseph S & Arutchelvam V |
|
|
| P306 |
Audit of thyroid
surgery in a district general hospital |
|
Srinivas Shankar U, Jordan T, Plant J, Movva R, Foster GE,
Rutter MK, Ewins DL & Worth RC |
|
|
| P307 |
Incidence and
prevalence of thyroid dysfunction in the general population of Tayside, Scotland |
|
Flynn RWV, MacDonald TM, Morris AD, Jung RT & Leese GP |
|
|
| P308 |
A change in role for
the endocrine nurse specialist - a survey |
|
Gorick S, Greenwood RH, Heyburn PJ, Sampson MJ & Temple
RC |
|
|
| P309 |
Mutation testing in
multiple endocrine neoplasia type 1 (men1): an audit |
|
Vaidya B, Hattersley AT & Ellard S |
|
|
| Novartis Awards Poster
Session |
| NP1 |
KAL-1 and KAL-2
ontogeny and in vitro function in human GnRH-1 developing system |
|
Gonzalez-Martinez D, Hu Y, Schofield J, Kim S & Bouloux
P |
|
|
| NP2 |
Bacterial and yeast
co-expression studies reveal hexose-6-phosphate dehydrogenase to be a crucial regulator of
11beta-hydroxysteroid dehydrogenase type 1 oxoreductase activity |
|
Walker OJ, Schneider SB, Edelstein M, Walker EA, Arlt W
& Stewart PM |
|
|